Skip to content

Advertisement

Antimicrobial Resistance

New Content Item © James Gathany/CDCEdited by Laith Yakob, London School of Hygiene and Tropical Medicine, UK

Antimicrobial resistance (AMR) causes almost 1 million deaths every year and its accelerating spread ensures an even greater burden in the years to come. At the 70th World Health Assembly held in Geneva in May 2017 the new Director-General of the WHO, Dr Tedros Adhanom, described AMR as "the perfect example of the complex, multi-sectorial, multi-stakeholder challenges we will increasingly face in the future".

 This series aims to explore the many facets of AMR, be they biological, clinical, environmental, epidemiological or economic. In particular, we welcome submission of research articles, reviews and opinion pieces focused on understanding AMR in a “One Health” context.

  1. Content type: Research article

    Rapid detection of rifampicin resistance is essential for early management and prevention of transmission of multidrug-resistant tuberculosis (MDR-TB). We studied the prevalence of rifampicin resistance of Mycoba...

    Authors: Balew Arega, Fiqrte Menbere and Yitagesu Getachew

    Citation: BMC Infectious Diseases 2019 19:307

    Published on:

  2. Content type: Research article

    The Lebanese Society of Infectious Diseases and Clinical Microbiology (LSIDCM) is involved in antimicrobial stewardship. In an attempt at guiding clinicians across Lebanon in regards to the proper use of antim...

    Authors: Nicholas Haddad, Souha S. Kanj, Lyn S. Awad, Dania I. Abdallah and Rima A. Moghnieh

    Citation: BMC Infectious Diseases 2019 19:293

    Published on:

  3. Content type: Research article

    Extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) represent a major problem in the management of nosocomial infections. However, ESBL-PE are not systematically monitored in African countries. T...

    Authors: Oumar Ouchar Mahamat, Manon Lounnas, Mallorie Hide, Yann Dumont, Abelsalam Tidjani, Kadidja Kamougam, Madina Abderrahmane, Julio Benavides, Jérôme Solassol, Anne-Laure Bañuls, Hélène jean-Pierre, Christian Carrière and Sylvain Godreuil

    Citation: BMC Infectious Diseases 2019 19:205

    Published on:

  4. Content type: Research article

    To evaluate the in vitro activities of plazomicin and comparator aminoglycosides and elucidate the underlying aminoglycoside resistance mechanisms among carbapenemase-producing K. pneumoniae isolates collected du...

    Authors: Irene Galani, Konstantina Nafplioti, Panagiota Adamou, Ilias Karaiskos, Helen Giamarellou and Maria Souli

    Citation: BMC Infectious Diseases 2019 19:167

    Published on:

    The Correction to this article has been published in BMC Infectious Diseases 2019 19:230

  5. Content type: Research article

    Clinical characteristics (taxonomy, virulence genes and antimicrobial resistance ) of Aeromonas in isolated from extra-intestinal and intestinal infections were investigated to describe epidemiology, associated v...

    Authors: Yanyan Zhou, Li Yu, Zheng Nan, Pingping Zhang, Biao Kan, Donghui Yan and Jianrong Su

    Citation: BMC Infectious Diseases 2019 19:158

    Published on:

  6. Content type: Technical advance

    Emerging antimicrobial resistance is a significant threat to human health. However, methods for rapidly diagnosing antimicrobial resistance generally require multi-day culture-based assays. Macrolide efflux ge...

    Authors: Megan M. Nelson, Christopher L. Waldron and John R. Bracht

    Citation: BMC Infectious Diseases 2019 19:144

    Published on:

  7. Content type: Research article

    Cirrhosis-associated immune dysfunction syndrome (CAIDS) has been identified in patients with liver cirrhosis (LC), predisposing them to a wide variety of infections. In patients with LC, healthcare-associated...

    Authors: Tamara Milovanovic, Igor Dumic, Jelena Veličkovic, Milica Stojkovic Lalosevic, Vladimir Nikolic and Ivan Palibrk

    Citation: BMC Infectious Diseases 2019 19:141

    Published on:

  8. Content type: Research article

    Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli are responsible for severe infections worldwide. Whereas their genotypic and pathogenic characteristics are not documented in Democratic Republic...

    Authors: Leonid M. Irenge, Jerome Ambroise, Bertrand Bearzatto, Jean-François Durant, Raphaël B. Chirimwami and Jean-Luc Gala

    Citation: BMC Infectious Diseases 2019 19:137

    Published on:

  9. Content type: Research article

    Pyrazinamide (PZA) is an important component of first-line drugs because of its distinctive capability to kill subpopulations of persistent Mycobacterium tuberculosis (MTB). The prodrug (PZA) is converted to its ...

    Authors: Muhammad Tahir khan, Shaukat Iqbal Malik, Sajid Ali, Nayyer Masood, Tariq Nadeem, Anwar Sheed Khan and Muhammad Tanvir Afzal

    Citation: BMC Infectious Diseases 2019 19:116

    Published on: